Cord Blood Banking Is The Fastest Growing Segment Fueling Growth Of Allogeneic Stem Cell Transplantation Market


https://www.coherentmarketinsights.com/industry-reports/allogeneic-stem-cell-transplantation-market
Allogeneic Stem Cell Transplantation Market



Market Overview:
Allogeneic stem cell transplantation involves transferring stem cells from a donor into a patient to replace damaged or destroyed stem cells. This process is typically used to treat blood cancers like leukemia and lymphoma as well as genetic disorders. Cord blood banking plays a crucial role in increasing the accessibility and availability of donor stem cells for transplantation procedures.

Market key trends:
The increasing prevalence of cancer diseases is a major factor driving the growth of the allogeneic stem cell transplantation market. Around 1.9 million new cancer cases are diagnosed in the U.S. annually. Moreover, the rising number of stem cell transplantation procedures performed worldwide is also propelling the growth of this market. Improving healthcare infrastructure along with growing investments to develop novel technologies in emerging countries is expected to create lucrative opportunities over the forecast period.

The global Allogeneic Stem Cell Transplantation Market Size is estimated to be valued at US$ 3.9 Bn in 2023 and is expected to exhibit a CAGR of 7.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Segment Analysis
The global allogeneic stem cell transplantation market is segmented into stem cell sources, treatment types, indications, and end users. The stem cell sources segment is further divided into bone marrow, peripheral blood stem cells, and umbilical cord blood. Peripheral blood stem cells are the most dominant sub-segment as these cells have higher stem cell count compared to bone marrow and can be collected faster with less discomfort to the donor.

Key Takeaways
The global allogeneic stem cell transplantation market is expected to witness high growth, exhibiting a CAGR of 7.9% over the forecast period, due to increasing prevalence of hematological malignancies and cancers.

Regional analysis
North America dominated the global market in 2023, accounting for nearly 35% of global revenue, owing to increasing health expenditure and rising adoption of stem cell therapies in the region. Asia Pacific is expected to grow at the fastest rate over the forecast period due to improving healthcare infrastructure and growing medical tourism in countries like China, India, and Japan.

Key players analysis
Key players operating in the allogeneic stem cell transplantation market are Celgene Corporation, Mesoblast Ltd., Pluristem Therapeutics Inc., MEDIPOST Co., Ltd., Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., Cellular Biomedicine Group, Inc., Biosolution Co., Ltd., StemCell Technologies Inc., Caladrius Biosciences, Inc., TiGenix N.V., ViaCord, Vericel Corporation, Regen Biopharma Inc., Gamida Cell Ltd., Histogenics Corporation, BrainStorm Cell Therapeutics Inc., Lineage Cell Therapeutics, Inc.


Comments

Popular posts from this blog

Agricultural Micronutrients Market Growth Accelerated By Increasing Need For Improved Soil Fertility

Dairy Alternative Market Expected To Reach USD 26.01 Billion By 2023

Antimicrobial Additives Market Growth Accelerated By Rising Demand From End-Use Industries